OTeixeira
TL3 Regular · Grenoble, FR
Clinician. Posts general information only, and says so every time.
Joined 27 September 2024 · last posted 1d · groups: clinicians
139 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #99 · Lounge › Introductions · 27 Jul 2026 · 27 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #96 · Compounds › Repair & healing peptides · 23 Jul 2026 · 1 like post #95 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #84 · Compounds › Retatrutide · 22 Jul 2026 · 4 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #101 · Start Here › Welcome · 22 Jul 2026 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #64 · Clinical › Prescriber conversations · 22 Jul 2026 · 0 likes This follows post #61 rather than contradicting it. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed…
-
Transit times by route, from a logged dataset Replied, post #26 · Sourcing › Logistics · 22 Jul 2026 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #54 · Sourcing › Regulatory · 22 Jul 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What published stability data actually covers, and what it does not Replied, post #12 · Practice › Storage & stability · 21 Jul 2026 · 23 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
What a reversed-phase purity number actually is Replied, post #70 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 3 likes Picking up post #67: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #13 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes post #12 answers the question as asked. The question underneath it is different. Understanding stopping rules: what would prompt stopping the compound? Adverse effect,…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #70 · Practice › Dosing & titration · 16 Jul 2026 · 11 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Priming a pen and whether the primed volume is wasted Replied, post #6 · Devices › Pens & autoinjectors · 14 Jul 2026 · 10 likes post #5 is right about the mechanism and I think understates the practical bit. Off-label dosing with a pen: if you want to deliver a dose different from the pen's…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #124 · Practice › Reconstitution · 14 Jul 2026 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #54 · Outcomes › Body composition · 12 Jul 2026 · 16 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #90 · Analytics › Home & field testing · 11 Jul 2026 · 0 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #21 · Evidence › Preprints · 11 Jul 2026 · 5 likes Worth separating two things that post #17 runs together. Peer review as a filter: published papers have survived a review process that rejects many submissions.…
-
What steady state means for the decision to escalate Replied, post #23 · Practice › Dosing & titration · 3 Jul 2026 · 21 likes post #22 answers the question as asked. The question underneath it is different. Steady state means the plasma concentration is stable from dose to dose. That happens…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #72 · Sourcing › Red flags · 29 Jun 2026 · 0 likes Worth separating two things that post #68 runs together. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by…
-
Journal club: what we got wrong in an earlier session Replied, post #36 · Evidence › Journal club · 28 Jun 2026 · 0 likes This follows post #33 rather than contradicting it. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #11 · Nutrition & Training › Protein & intake · 28 Jun 2026 · 12 likes I read post #9 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
A fridge failure and how I assessed the contents afterwards Replied, post #15 · Devices › Cold chain · 25 Jun 2026 · 5 likes post #14 answers the question as asked. The question underneath it is different. Temperature excursions: brief excursions above 8 °C are tolerable for most compounds.…
-
Electrolyte supplements: which ones do anything Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 21 Jun 2026 · 17 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
Batch numbers that do not match the vial label Replied, post #29 · Sourcing › Red flags · 14 Jun 2026 · 9 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Talking to a therapist about this specifically Replied, post #12 · Wellbeing › Mental health · 12 Jun 2026 · 1 like This follows post #9 rather than contradicting it. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function,…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #41 · Clinical › Bloodwork · 7 Jun 2026 · 28 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Tracking a shortage from primary sources rather than rumour Replied, post #37 · Access › Shortages · 5 Jun 2026 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
A pooled estimate that changed when one trial was added Replied, post #5 · Evidence › Meta-analyses · 1 Jun 2026 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for…
-
Injection volume, overload, and peak distortion Replied, post #29 · Analytics › HPLC & UHPLC · 31 May 2026 · 10 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
A site rotation scheme that is easy enough to actually follow Replied, post #71 · Practice › Administration · 24 May 2026 · 0 likes Coming back to post #69, because the follow-up matters more than the original answer. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #82 · Compounds › Tirzepatide · 23 May 2026 · 6 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Prescription requirements and telehealth models — a second dataset Replied, post #38 · Sourcing › Regulatory · 22 May 2026 · 5 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #10 · Clinical › Comorbidities · 20 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #5 · Sourcing › Red flags · 19 May 2026 · 12 likes post #4 is right about the mechanism and I think understates the practical bit. Exaggerated claims without documentation: every compound has limits. No peptide is "100%…
-
Revisiting: Absolute versus relative contraindications Replied, post #86 · Safety › Contraindications · 9 May 2026 · 6 likes post #85 answers the question as asked. The question underneath it is different. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
-
The headache that turns out to be dehydration — the long version Replied, post #31 · Nutrition & Training › Hydration & electrolytes · 6 May 2026 · 23 likes I read post #29 twice before replying, because I had assumed the opposite. Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #27 · Analytics › COA interpretation · 2 May 2026 · 7 likes I read post #25 twice before replying, because I had assumed the opposite. Reading old certificates: if a certificate is dated years ago, the lot it describes might be…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #18 · Pharmacology › Pharmacokinetics · 16 Apr 2026 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #30 · Meta › Announcements · 13 Apr 2026 · 8 likes On post #26 — agreed on the reasoning, with one qualification. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for…
-
Spike-and-recover accuracy for a peptide assay Replied, post #66 · Analytics › Method validation · 9 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #29 · Practice › Administration · 3 Apr 2026 · 1 like Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Sample handling between despatch and injection Replied, post #14 · Analytics › Method validation · 2 Apr 2026 · 3 likes I read post #12 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #74 · Clinical › Bloodwork · 2 Apr 2026 · 24 likes I read post #72 twice before replying, because I had assumed the opposite. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #88 · Pharmacology › Pharmacokinetics · 30 Mar 2026 · 3 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Run-in periods and the population they select Replied, post #89 · Evidence › Trials · 27 Mar 2026 · 0 likes This follows post #86 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #108 · Clinical › Bloodwork · 22 Mar 2026 · 33 likes post #107 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #8 · Practice › Side effects · 17 Mar 2026 · 3 likes On post #4 — agreed on the reasoning, with one qualification. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop…
-
Grapefruit: why this class is not the class that cares Replied, post #33 · Practice › Interactions · 12 Mar 2026 · 0 likes post #32 answers the question as asked. The question underneath it is different. Food interactions: most interactions are absorption interactions. Some medications…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #49 · Analytics › Impurities & related substances · 11 Mar 2026 · 0 likes Coming back to post #47, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
[2026 update] What a purity-only report leaves out Replied, post #49 · Sourcing › Independent verification · 10 Mar 2026 · 29 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #24 · Evidence › Trials · 8 Mar 2026 · 2 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Choosing which test to pay for, given a fixed budget Replied, post #16 · Sourcing › Independent verification · 7 Mar 2026 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #137 · Compounds › Semaglutide · 7 Mar 2026 · 3 likes Worth separating two things that post #133 runs together. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal…
-
Contributing data without breaching anyone's privacy Replied, post #61 · Data & Tools › Datasets · 6 Mar 2026 · 1 like Worth separating two things that post #57 runs together. Community-collected datasets: some members have compiled datasets from their own experience and shared them.…
-
The lowest dose that does anything: is that a real question? Replied, post #57 · Practice › Dosing & titration · 5 Mar 2026 · 4 likes Coming back to post #55, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #85 · Access › International · 1 Feb 2026 · 2 likes post #84 answers the question as asked. The question underneath it is different. Insurance and coverage: coverage decisions are national. A compound approved in one…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #16 · Clinical › Special populations · 21 Jan 2026 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #66 · Access › International · 21 Jan 2026 · 26 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #8 · Clinical › Comorbidities · 31 Dec 2025 · 2 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Reverse causation in a cohort study of weight and outcome Replied, post #6 · Evidence › Study critique · 28 Dec 2025 · 23 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #44 · Sourcing › Regulatory · 26 Dec 2025 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #78 · Compounds › Oral incretins · 25 Dec 2025 · 1 like I read post #76 twice before replying, because I had assumed the opposite. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial.…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #15 · Compounds › Oral incretins · 22 Dec 2025 · 5 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Publishing an inconvenient result: a case study — the long version Replied, post #73 · Sourcing › Independent verification · 17 Dec 2025 · 2 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Tracking a preprint to publication: a worked example Replied, post #35 · Evidence › Preprints · 3 Dec 2025 · 12 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
A payment that went through twice: how it was resolved Replied, post #10 · Sourcing › Payments · 2 Dec 2025 · 0 likes Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for cancellation is important before the first charge.
-
What a purity-only report leaves out Replied, post #97 · Sourcing › Independent verification · 21 Nov 2025 · 3 likes Worth separating two things that post #93 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Tracking that stops updating and then resumes — the long version Replied, post #39 · Sourcing › Logistics · 16 Nov 2025 · 3 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
History of disordered eating and why it changes the conversation Replied, post #22 · Clinical › Special populations · 13 Nov 2025 · 31 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #36 · Compounds › Oral incretins · 9 Nov 2025 · 0 likes I read post #34 twice before replying, because I had assumed the opposite. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial.…
-
[2026 update] What steady state means for the decision to escalate Replied, post #16 · Practice › Dosing & titration · 6 Nov 2025 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #80 · Safety › Adverse events · 1 Nov 2025 · 17 likes This follows post #77 rather than contradicting it. Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible.…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #125 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes Coming back to post #123, because the follow-up matters more than the original answer. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #8 · Outcomes › Body composition · 23 Oct 2025 · 32 likes post #7 answers the question as asked. The question underneath it is different. Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #16 · Clinical › Special populations · 20 Oct 2025 · 0 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
How to read a forest plot, properly, from scratch Replied, post #43 · Evidence › Trials · 20 Oct 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Revisiting: Power cut for eleven hours: how I assessed it afterwards Replied, post #5 · Practice › Storage & stability · 19 Oct 2025 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Container choice matters: the material of the vial, the rubber closure, the fill…
-
Documentation that appears only after payment Replied, post #52 · Sourcing › Red flags · 18 Oct 2025 · 17 likes Worth separating two things that post #48 runs together. Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin…
-
Follow-up: Why appetite effects are mostly central Replied, post #61 · Pharmacology › Receptor biology · 8 Oct 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #112 · Evidence › Study critique · 16 Sep 2025 · 26 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Managing an unplanned gap in supply — what changed since Replied, post #57 · Access › Shortages · 8 Sep 2025 · 5 likes Coming back to post #55, because the follow-up matters more than the original answer. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #31 · Analytics › Method validation · 4 Sep 2025 · 30 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
MALDI versus ESI for a quick identity check Replied, post #3 · Analytics › Mass spectrometry · 2 Sep 2025 · 16 likes post #2 is right about the mechanism and I think understates the practical bit. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #116 · Practice › Reconstitution · 31 Aug 2025 · 3 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #102 · Compounds › Secretagogues & GH axis · 26 Aug 2025 · 13 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #49 · Practice › Side effects · 23 Aug 2025 · 2 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Publishing an inconvenient result: a case study Replied, post #67 · Sourcing › Independent verification · 16 Aug 2025 · 15 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Which panel is worth repeating and which is worth ignoring Replied, post #80 · Clinical › Bloodwork · 9 Aug 2025 · 11 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #2 · Sourcing › Regulatory · 7 Aug 2025 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Are there stupid questions here? A staff answer, at length Replied, post #46 · Start Here › Welcome · 6 Aug 2025 · 17 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #49 · Evidence › Journal club · 6 Aug 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #5 · marked as the solution · Start Here › How to Ask · 3 Aug 2025 · 7 likes I read post #3 twice before replying, because I had assumed the opposite. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable…
-
Travel coolers and how long they really hold Replied, post #27 · Devices › Cold chain · 2 Aug 2025 · 5 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Travel coolers and how long they really hold Replied, post #16 · Devices › Cold chain · 1 Aug 2025 · 0 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
Substitution between formats during a shortage Replied, post #28 · Access › Shortages · 25 Jul 2025 · 25 likes I read post #26 twice before replying, because I had assumed the opposite. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Repeatability versus intermediate precision Replied, post #92 · Analytics › Method validation · 29 Jun 2025 · 8 likes Coming back to post #90, because the follow-up matters more than the original answer. Precision and repeatability: within-run and between-run variability of the method.…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #54 · Evidence › Journal club · 26 Jun 2025 · 26 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #52 · Evidence › Trials · 13 Jun 2025 · 1 like Coming back to post #50, because the follow-up matters more than the original answer. Risk of bias: structured appraisal of internal validity. Key things to assess:…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #18 · Sourcing › Regulatory · 12 Jun 2025 · 0 likes On post #14 — agreed on the reasoning, with one qualification. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
Storing a pen in use versus a pen unopened Replied, post #18 · Devices › Pens & autoinjectors · 4 Jun 2025 · 32 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #126 · Compounds › Cagrilintide & amylin analogues · 1 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #44 · Practice › Storage & stability · 19 May 2025 · 5 likes Picking up post #41: that is the part I would want checked first. Published stability data applies specifically to the formulation studied, under the specific…
-
Coverage for the indication versus for the drug Replied, post #56 · Access › Insurance & coverage · 7 May 2025 · 4 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Certificates issued by the seller versus by a laboratory Replied, post #59 · Analytics › COA interpretation · 24 Apr 2025 · 18 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Follow-up: Requesting a page: what makes a good request Replied, post #19 · Documentation › Wiki requests · 8 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #35 · Outcomes › Progress reports · 4 Apr 2025 · 0 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #52 · Access › Pricing · 2 Apr 2025 · 12 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Counter-ion content and its effect on measured mass Replied, post #8 · Analytics › Mass spectrometry · 30 Mar 2025 · 0 likes Worth separating two things that post #4 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
An emergency department visit, described afterwards Replied, post #6 · Safety › Adverse events · 25 Mar 2025 · 32 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #29 · Compounds › Tirzepatide · 23 Mar 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #8 · Evidence › Journal club · 10 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What a 2 ppm match establishes, and what it does not Replied, post #4 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. What mass accuracy establishes: the measured mass is consistent with a specific composition.…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #80 · Access › International · 5 Mar 2025 · 0 likes post #79 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #51 · Sourcing › Red flags · 11 Feb 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Protein density versus volume when you cannot eat much Replied, post #104 · Nutrition & Training › Protein & intake · 10 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #33 · Evidence › Meta-analyses · 31 Jan 2025 · 16 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
UK access routes, dated and sourced — a second dataset Replied, post #32 · Regional › UK & Ireland · 28 Jan 2025 · 0 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
What we do not know about retatrutide, listed explicitly Replied, post #67 · Compounds › Retatrutide · 23 Jan 2025 · 3 likes On post #63 — agreed on the reasoning, with one qualification. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #44 · Compounds › Oral incretins · 12 Jan 2025 · 1 like Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #4 · Compounds › Repair & healing peptides · 5 Jan 2025 · 0 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #15 · Pharmacology › Receptor biology · 31 Dec 2024 · 0 likes This follows post #12 rather than contradicting it. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #93 · Compounds › Semaglutide · 24 Dec 2024 · 12 likes Worth separating two things that post #89 runs together. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal…
-
Fixed versus detachable needles: the trade-offs Replied, post #69 · Devices › Syringes & needles · 24 Dec 2024 · 5 likes Picking up post #66: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #17 · Data & Tools › Calculators · 12 Dec 2024 · 24 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Washout with a one-week half-life: the arithmetic Replied, post #77 · Research Methods › N-of-1 designs · 6 Dec 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Washout with a one-week half-life: the arithmetic Replied, post #28 · Research Methods › N-of-1 designs · 27 Nov 2024 · 7 likes post #27 is right about the mechanism and I think understates the practical bit. Objective versus subjective measures: subjective measures (how you feel) are vulnerable…
-
Reading a supplementary appendix and finding the interesting part Replied, post #31 · Evidence › Trials · 26 Nov 2024 · 0 likes post #30 is right about the mechanism and I think understates the practical bit. Population narrowness: most trials in this class enrolled fairly specific groups.…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #42 · Compounds › Tirzepatide · 18 Nov 2024 · 12 likes This follows post #39 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Time to steady state after a dose increase Replied, post #95 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 23 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Why I ask for the gradient before I discuss the number Replied, post #18 · Analytics › HPLC & UHPLC · 5 Sep 2024 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #2 · Compounds › Retatrutide · 23 Aug 2024 · 28 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #35 · Analytics › Mass spectrometry · 17 Aug 2024 · 19 likes This follows post #32 rather than contradicting it. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #29 · Clinical › Prescriber conversations · 30 Jul 2024 · 11 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
The mass-error checker and its intended scope Replied, post #153 · Data & Tools › Calculators · 25 Jul 2024 · 0 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #83 · Compounds › Retatrutide · 22 Jul 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The mass-error checker and its intended scope Replied, post #117 · Data & Tools › Calculators · 12 Jul 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #107 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes I read post #105 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #12 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
The mass-error checker and its intended scope Replied, post #92 · Data & Tools › Calculators · 2 Jul 2024 · 3 likes Worth separating two things that post #88 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Cold packs, phase-change material, and what survives ten days Replied, post #2 · Sourcing › Logistics · 8 Jun 2024 · 8 likes Picking up the opening post: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently,…